Since being opened in June 2020, Village Landais Alzheimer (VLHE) has become home to approximately 110 people with Alzheimer's disease or a related illness. This experimental project, the only of its kind in France, is based on non-medication treatments and support tailored to the patient. The research study involves comparative analysis of economic data (program costs and use of treatments) and clinical data (cognitive and functional evolution) from village residents and residents in nursing homes. The objective is to evaluate and put into perspective the clinical efficacy and economic cost of each of the program's models, as well as the effects on healthcare professionals and carers.
This project is led by the PHARes team from Bordeaux Population Health, under the direction of Jérôme Wittwer, University Professor of Economics at the Bordeaux School of Public Health (ISPED).
The first dementia village was created in the Netherlands in 2009, with the concept then being launched in France by Henri Emmanuelli. The challenge of this project is to assess the effectiveness and overall cost of this innovative form of care using medico-economic analysis and to thereby provide information to public decision- makers who are considering establishing such.

